Effect of renal disease on renal uptake and excretion of insulin in man.

No abstract is available for this paper.

• Publication year

  1970

• Venue

  New England Journal of Medicine

• Publication date

  1970-01-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM197001222820402PMID 5409813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of the Kidney in Insulin Metabolism and Excretion

  1968cited by this paper
• Evidence from combined immunoassay and radioautography procedures that intact insulin-125-I molecules are concentrated by mouse kidney proximal tubule cells.

  1967cited by this paper
• Urine insulin in normal subjects.

  1967cited by this paper
• Radioimmunoassay of insulin in urine

  1967cited by this paper
• The renal handling of insulin.

  1967cited by this paper
• Immunoassay of insulin in human urine.

  1966cited by this paper
• Role of the Kidney in the Disposal of Radioiodinated and Nonradioiodinated Insulin in Dogs

  1966cited by this paper
• Effect of chronic renal failure and hemodialysis on carbohydrate metabolism.

  1966cited by this paper
• Studies of an Inhibitor of the Two Antibody Immunoassay System

  1964cited by this paper
• The Role of the Kidney in the Disposal of Insulin in Rats

  1963cited by this paper
• Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats

  1963cited by this paper
• Degradation of Insulin by Tissue Extracts of Normal and Nephrotic Rats.∗

  1963cited by this paper
• The renal clearance of I-131 during the infusion of NaI-131 and insulin-I-131.

  1961cited by this paper
• FUNCTIONAL CHARACTERISTICS OF RENOVASCULAR HYPERTENSION

  1961cited by this paper
• Apparent remission of a severe diabetic on developing the Kimmelstiel-Wilson syndrome.

  1961cited by this paper
• The Renal Clearance of I131 During the Infusion of Nal131 and Insulin-I131

  1961cited by this paper
• THE RELATIONSHIP BETWEEN THE MECHANISM OF ACTION OF THE SULFONYLUREAS AND THE SECRETION OF INSULIN INTO THE PORTAL CIRCULATION

  1959cited by this paper
• Effect of Experimental Nephrosis on Alloxan Diabetes in Rats

  1958cited by this paper
• Metabolism of insulin-I 131 and glucagon-I 131 in the kidney of the rat.

  1958cited by this paper
• Metabolism of Insulin-I131 and Glucagon-I131 in the Kidney of the Rat

  1958cited by this paper
• Effect of Kimmelstiel-Wilson syndrome on insulin requirements in diabetes.

  1955cited by this paper
• The renal clearance of alkali-stable inulin.

  1955cited by this paper
• Distribution and degradation studies with insulin I131.

  1954cited by this paper
• Amelioration of diabetes and striking rarity of acidosis in patients with Kimmelstiel-Wilson lesions.

  1951cited by this paper
• THE URINARY EXCRETION OF INSULIN BY NORMAL AND DIABETIC SUBJECTS.

  1948cited by this paper
• THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN.

  1945cited by this paper
• The insulin requirement of man after total pancreatectomy.

  1944cited by this paper
• On the disappearance from the blood of intravenously injected insulin

  1940cited by this paper
• A RAPID PHOTOELECTRIC METHOD FOR THE DETERMINATION OF GLUCOSE IN BLOOD AND URINE

  1937cited by this paper

• The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa

  2024cites this paper
• Long-Term High-Fat Diet Decreases Renal Insulin-Degrading Enzyme Expression and Function by Inhibiting the PPARγ Pathway.

  2023cites this paper
• Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance

  2023cites this paper
• Use of Classes of Antihyperglycemic Agents in People With Type 2 Diabetes Based on Level of Estimated Glomerular Filtration Rate.

  2023cites this paper
• Measuring and estimating insulin resistance in clinical and research settings

  2022cites this paper
• Insulin Clearance in Obesity and Type 2 Diabetes

  2022cites this paper
• Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity.

  2022cites this paper
• Carbohydrate metabolism in chronic renal disease

  2022cites this paper
• Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease

  2022cites this paper
• Insulin Clearance in Health and Disease.

  2022cites this paper
• Insulinoma mimic: methadone-induced hypoglycaemia

  2022cites this paper
• Current Pharmacological Intervention and Medical Management for Diabetic Kidney Transplant Recipients

  2021cites this paper
• Diabetes mellitus in dialysis and renal transplantation

  2021cites this paper
• In Reply: “On Insulin Kinetics Following High-Dose Insulin Therapy, and When to Stop Therapy”

  2021cites this paper
• RENAL MASS REDUCTION INCREASES THE RESPONSE TO EXOGENOUS INSULIN INDEPENDENT OF ACID-BASE STATUS OR PLASMA INSULIN LEVELS IN RATS.

  2021cites this paper
• New‐onset type 1 diabetes complicated by diabetic ketoacidosis and severe sepsis requiring extracorporeal membrane oxygenation and kidney replacement therapy

  2021cites this paper
• Renal gluconeogenesis: an underestimated role of the kidney in systemic glucose metabolism.

  2020cites this paper
• Effect of Insulin on Proximal Tubules Handling of Glucose: A Systematic Review

  2020cites this paper
• Carbohydrates and Lipids

  2020cites this paper
• Tubular Secretory Clearance is Associated with Whole-Body Insulin Clearance.

  2020cites this paper
• Hypoglycemia as a complication of intravenous insulin to treat hyperkalemia in the emergency department

  2019cites this paper
• Optimisation of the Investigation of Antibody-Mediated Dysglycaemia

  2019cites this paper
• Metabolic and Nutritional Complications of Acute Kidney Injury

  2019cites this paper
• Assessment of hepatic insulin extraction from in vivo surrogate methods of insulin clearance measurement.

  2018cites this paper
• Carbohydrate Metabolism in Chronic Kidney Disease

  2018cites this paper
• Metabonomic Profiling Reveals Difference in Altered Metabolic Pathways Between Chronic Kidney Disease and High-Fat-Induced Insulin Resistance in Rats

  2018cites this paper
• Correlations of the glycemic variability with oxidative stress and erythrocytes membrane stability in patients with type 1 diabetes under intensive treatment.

  2018cites this paper
• Managing hyperglycaemia in patients with diabetes and diabetic nephropathy–chronic kidney disease Summary of recommendations 2018

  2018cites this paper
• Platelet activation in the presence of neutral protamine Hagedorn insulin: a new feature of antibodies against protamine/heparin complexes

  2017cites this paper
• Insulin resistance in predialytic, nondiabetic, chronic kidney disease patients: A hospital-based study in Eastern Uttar Pradesh, India.

  2017cites this paper
• Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?

  2017cites this paper
• Effect of Short-term Erythropoietin Therapy on Insulin Resistance and Serum Levels of Leptin and Neuropeptide Y in Hemodialysis Patients

  2017cites this paper
• In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog

  2016cites this paper
• Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations

  2016cites this paper
• Incorporating bolus and infusion pharmacokinetics into the ICING insulin model.

  2016cites this paper
• Addition of 20-kDa PEG to Insulin Lispro Alters Absorption and Decreases Clearance in Animals

  2016cites this paper
• Impaired Glucose and Insulin Homeostasis in Moderate-Severe CKD.

  2016cites this paper
• Effect of Insulin Resistance in Chronic Kidney Disease

  2016cites this paper
• MICROVASCULAR COMPLICATIONS — NEPHROPATHY ( T ISAKOVA , SECTION EDITOR ) Update on Glycemic Control for the Treatment of Diabetic Kidney Disease

  2015cites this paper
• Inhibiteurs du SGLT2 : mécanisme d’action, effets rénaux et effets sur la pression artérielle

  2015cites this paper
• The incretin effect does not differ in trained and untrained, young, healthy men

  2014cites this paper
• Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects

  2014cites this paper
• Impact of Left Ventricular Assist Device on Diabetes Management: An Evaluation through Case Analysis and Clinical Impact

  2014cites this paper
• Insulin resistance in chronic kidney disease: new lessons from experimental models.

  2014cites this paper
• Achieving glycaemic targets with basal insulin in T2DM by individualizing treatment

  2014cites this paper
• Carbohydrate Metabolism in Kidney Disease and Kidney Failure

  2013cites this paper
• Renal Disposition of Drugs and Translation to Dosing Strategies

  2013cites this paper
• Glycemic Control in Diabetic Patients on Long-Term Maintenance Dialysis

  2013cites this paper
• Insulin Resistance and Muscle Metabolism in Chronic Kidney Disease

  2013cites this paper
• p-Cresyl sulfate promotes insulin resistance associated with CKD.

  2013cites this paper
• Insulin resistance and protein metabolism in chronic hemodialysis patients.

  2013cites this paper
• Kidney Injury, Insulin Therapy, and Hypoglycemia

  2012cites this paper
• Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support.

  2011cites this paper
• Insulin Resistance, Obesity, Hypertension, and Renal Sodium Transport

  2011cites this paper
• Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study.

  2011cites this paper
• Insulin Resistance and Protein Energy Metabolism in Patients with Advanced Chronic Kidney Disease

  2010cites this paper
• New-onset diabetes mellitus after kidney transplantation in Denmark.

  2010cites this paper
• Chapter 47 – Metabolic and Nutritional Complications of Acute Kidney Injury

  2010cites this paper
• Nutritional therapy in kidney failure.

  2009cites this paper
• The treatment of end-stage renal failure in insulin-dependent diabetic patients.

  2009cites this paper
• Managing diabetes in hemodialysis patients: Observations and recommendations

  2009cites this paper
• Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics

  2009cites this paper
• Innovation in the Treatment of Uremia: Proceedings from the Cleveland Clinic Workshop: Inflammation and Insulin Resistance as Novel Mechanisms of Wasting in Chronic Dialysis Patients

  2009cites this paper
• Managing diabetes in hemodialysis patients : Observations and recommendations

  2009cites this paper
• Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure.

  2008cites this paper
• Insulin therapy in renal disease

  2008cites this paper
• CHAPTER 98 – Disposition and Dose Requirements of Drugs in Renal Insufficiency

  2008cites this paper
• Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease.

  2008cites this paper
• LIVER FAT IN THE METABOLIC SYNDROME AND TYPE 2 DIABETES

  2008cites this paper
• Supporting Literature for an Evidence-Based Metabolic Support Practice

  2008cites this paper
• Insulin and its role in chronic kidney disease

  2008cites this paper
• B-cell response to a standardized breakfast in end-stage renal failure

  2007cites this paper
• Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients.

  2007cites this paper
• An old patient with end stage renal disease and sudden onset of confusion and lethargy

  2006cites this paper
• Renal handling of adipokines.

  2006cites this paper
• An old patient with end stage renal disease and sudden onset of confusion and lethargy.

  2006cites this paper
• Post-Transplantation Diabetes Mellitus

  2005cites this paper
• Acute renal failure in diabetics

  2004cites this paper
• Normal Insulin Secretion in Humans

  2003cites this paper
• Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*

  2003cites this paper
• Diabetic nephropathy.

  2003cites this paper
• The pharmacokinetics of pioglitazone in patients with impaired renal function.

  2003cites this paper
• Metabolic aspects on diabetic nephropathy

  2003cites this paper
• METAB LISM IN CHRONIC KIDNEY DISEASE Drug Metabolism Considerations in Patients With Chronic Kidney Disease

  2002cites this paper
• Drug Metabolism Considerations in Patients With Chronic Kidney Disease

  2002cites this paper
• A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephrophathy

  2002cites this paper
• Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment

  2001cites this paper
• Management of Hyperinsulinemia with Diazoxide in an Elderly Hemodialysis Patient

  2001cites this paper
• Insulin secretion in uremia.

  2001cites this paper
• Intraperitoneal Versus Subcutaneous Insulin Treatment in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis Therapy

  2001cites this paper
• Pharmacokinetics of repaglinide in subjects with renal impairment

  2000cites this paper
• Therapie des Diabetes mellitus

  2000cites this paper
• Disturbances in carbohydrate, protein and trace metal metabolism in uremia and dialysis patients.

  2000cites this paper
• Insulin assays and reference values.

  1999cites this paper
• Effect of hyperinsulinemia on renal function in a general Japanese population: the Hisayama study.

  1999cites this paper
• Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients.

  1997cites this paper
• Processing of 125I-insulin by polarized cultured kidney cells.

  1996cites this paper
• Spontaneous hypoglycaemia in chronic renal failure.

  1996cites this paper
• "Spontaneous" hypoglycaemia: facing a hydra.

  1996cites this paper
• Pharmacokinetic Basis for the Safety of Glimepiride in Risk Groups of NIDDM Patients

  1996cites this paper